119 related articles for article (PubMed ID: 25927946)
1. Development of a serological assay to predict antibody bactericidal activity against non-typeable Haemophilus influenzae.
Ercoli G; Baddal B; Alessandra G; Marchi S; Petracca R; Aricò B; Pizza M; Soriani M; Rossi-Paccani S
BMC Microbiol; 2015 Apr; 15():87. PubMed ID: 25927946
[TBL] [Abstract][Full Text] [Related]
2. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
[TBL] [Abstract][Full Text] [Related]
4. EF-Tu From Non-typeable
Thofte O; Su YC; Brant M; Littorin N; Duell BL; Alvarado V; Jalalvand F; Riesbeck K
Front Immunol; 2018; 9():2910. PubMed ID: 30619274
[TBL] [Abstract][Full Text] [Related]
5. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
Dahlberg-Lagergård T
Acta Pathol Microbiol Immunol Scand C; 1982 Aug; 90(4):209-16. PubMed ID: 6982592
[TBL] [Abstract][Full Text] [Related]
6. Systemic humoral immunity to non-typeable Haemophilus influenzae.
King PT; Ngui J; Gunawardena D; Holmes PW; Farmer MW; Holdsworth SR
Clin Exp Immunol; 2008 Sep; 153(3):376-84. PubMed ID: 18803761
[TBL] [Abstract][Full Text] [Related]
7. Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse.
Tabatabaee Bafroee AS; Siadat SD; Mousavi SF; Aghasadeghi MR; Khorsand H; Nejati M; Sadat SM; Mahdavi M
Microb Pathog; 2016 Sep; 98():106-11. PubMed ID: 27377430
[TBL] [Abstract][Full Text] [Related]
8. Invasive African nontyphoidal Salmonella requires high levels of complement for cell-free antibody-dependent killing.
Goh YS; MacLennan CA
J Immunol Methods; 2013 Jan; 387(1-2):121-9. PubMed ID: 23085530
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains.
Neary JM; Yi K; Karalus RJ; Murphy TF
Infect Immun; 2001 Feb; 69(2):773-8. PubMed ID: 11159967
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
Khan MN; Kaur R; Pichichero ME
FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
[TBL] [Abstract][Full Text] [Related]
11. Nontypeable Haemophilus influenzae Lipooligosaccharide Expresses a Terminal Ketodeoxyoctanoate
Apicella MA; Coffin J; Ketterer M; Post DMB; Day CJ; Jen FE; Jennings MP
mBio; 2018 Jul; 9(4):. PubMed ID: 30065093
[TBL] [Abstract][Full Text] [Related]
12. A fluorescent multiplexed bead-based immunoassay (FMIA) for quantitation of IgG against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis protein antigens.
Andrade DC; Borges IC; Laitinen H; Ekström N; Adrian PV; Meinke A; Barral A; Nascimento-Carvalho CM; Käyhty H
J Immunol Methods; 2014 Mar; 405():130-43. PubMed ID: 24530690
[TBL] [Abstract][Full Text] [Related]
13. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
Akkoyunlu M; Forsgren A
APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
Townsend K; Ladhani SN; Findlow H; Borrow R
Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
[TBL] [Abstract][Full Text] [Related]
16. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae.
McGehee JL; Radolf JD; Toews GB; Hansen EJ
Am J Respir Cell Mol Biol; 1989 Sep; 1(3):201-10. PubMed ID: 2624760
[TBL] [Abstract][Full Text] [Related]
17. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
18. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
19. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
[TBL] [Abstract][Full Text] [Related]
20. Antibodies directed at a conserved motif in loop 6 of outer membrane protein P2 of nontypeable Haemophilus influenzae recognize multiple strains in immunoassays.
Neary JM; Murphy TF
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):251-61. PubMed ID: 16487307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
